Based on the increased expression of IL-1β following FGFR1 activation and the link between IL-1β and breast cancer [8], we hypothesised that IL-1β may be an important factor in the formation of iFGFR1-induced proliferative lesions. The gene discussed is IL1B; the disease is breast carcinoma.